treatment of minimal hepatic encephalopathy

Clicks: 181
ID: 195010
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #43 of 78 articles by views in lontar komputer

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Minimal hepatic encephalopathy (MHE) is defined as early hepatic encephalopathy without grossly evident neurologic abnormalities, but with cognitive deficits that can be revealed by psychometric testing. However, numerous studies have shown a lack of obvious clinical manifestations in MHE patients, and there is no international unified diagnostic gold standard for this disease. Affected patients′ quality of life and ability to work are markedly impaired, and some even gradually progress to symptomatic hepatic encephalopathy. The treatment methods for MHE mainly include eliminating the precipitating factors for this disease and medication. This review presents the options for treatment of MHE and gives an objective evaluation of the efficacy of each treatment scheme. Currently, several treatment methods are used together, but no studies have demonstrated that combined use of treatment methods can improve the treatment outcome.
Reference Key
kai2014linchuangtreatment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;ZHAO Kai
Journal lontar komputer
Year 2014
DOI
10.3969/j.issn.1001-5256.2014.10.030
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.